Quanterix Files Updated Investor Presentation Highlighting Compelling Benefits of Combination BILLERICA, Mass. and MARLBOROUGH, Mass. – Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, and Akoya Biosciences (NASDAQ: AKYA), The Spatial Biology Company®, today announced an amendment to the terms of their previously announced merger agreement. Under the amended terms, Quanterix will issue approximately 7.76 […]
Forms Special Committee of the Board to Lead Evaluation of Viable Options for Maximizing Shareholder Value Engages Independent Financial and Legal Advisors to Support Thorough Process Remains Committed to Maintaining Focus on Cost Containment, Cash Preservation and Near-Term Initiatives to Enhance Value Farmingdale, NY — Enzo Biochem, Inc. (OTCQX: ENZB) (“Enzo” or the “Company”) today […]
The Board of Directors of Biotage has concluded to recommend that the shareholders of Biotage accept the public offer from RWK BidCo, based on the assessment outlined below. Background This statement is made by the Board of Directors of Biotage AB (publ) (“Biotage” or the “Company”) (the “Board”) pursuant to section II.19 of the Nasdaq […]
Combining GeneDx’s industry-leading rare disease data asset and Fabric Genomics’ AI-powered platform furthers the Company’s leadership and creates an unrivaled platform to deliver global access to genomic information Accelerates the NICU, enables newborn screening, and opens global market opportunities with on-site sequencing and decentralized interpretation GAITHERSBURG, Md. & OAKLAND, Calif.–GeneDx (Nasdaq: WGS), a leader in […]
Bruker and RECIPE are pioneering the high-throughput ‘chrom-free’ ClinDART triple-quad MS platform for robust and cost-effective therapeutic drug monitoring assays MUNICH–Bruker Corporation (NASDAQ: BRKR) today announced a majority investment in RECIPE Chemicals + Instruments GmbH, based in Munich, Germany. RECIPE is a leading European provider of vendor-agnostic therapeutic drug monitoring (TDM) and other clinical in […]
Baytek International Acquired by Datacor Corpus Christi, TX – Baytek International, a leader in Laboratory Information Management Systems (LIMS), statistical quality control (SQC), and instrument automation solutions, announced today its acquisition by Datacor, Inc., a provider of process manufacturing, engineering, and chemical distribution software. Founded in 1981, Datacor helps professionals maximize productivity, use data as […]
NEW YORK and WOONSOCKET, R.I. — Surplus Solutions LLC (“Surplus Solutions”), a portfolio company of NMS Capital (“NMS”), announced today the acquisition of Certified Genetool (or the “Company”), a San Francisco-based provider of certified laboratory instruments and technical services. The acquisition expands Surplus Solutions’ operational capabilities and supports continued growth in the biotechnology, pharmaceutical, and […]
BICO Group AB (“BICO”) has entered into an agreement to divest MatTek Corp (“MatTek”) and Visikol Inc (“Visikol”) to Sartorius Lab Holding GmbH (“Sartorius”) for USD 80m, on a cash and debt-free basis. The divestment follows the Group’s updated strategy with focus on lab automation and selected workflows. The proceeds from the transaction will be […]
Acquisition will advance Sartorius’ cell culture portfolio with 3D microtissue models and primary cells MatTek’s solutions are highly compatible with Sartorius’ cell analysis instruments, reagents and AI models for faster and more effective drug development Göttingen, Germany — The life science group Sartorius has agreed to acquire MatTek Corp, including Visikol Inc, from BICO Group […]
Männedorf, Switzerland – Tecan Group (SIX Swiss Exchange: TECN) today announced an agreement to acquire certain assets relating to key ELISA immunoassay products from Cisbio Bioassays SAS, a subsidiary of the global life sciences and diagnostics company, Revvity Inc. The asset purchase includes the manufacturing process of four ELISA kits – two in vitro diagnostic (IVD) products for specialty […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
